"Today, we're proud to announce an important update to our label for FLUBLOK, from one of Sanofi's largest flu vaccine safety studies ever done in pregnant individuals, an important at-risk ...
Madison County Board approves multiple vaccine contracts and emergency appropriations, including grants for public health and ...
The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi SA (NASDAQ:SNY) and ...
Sanofi has announced the launch of its high-dose egg-based quadrivalent influenza vaccine (QIV-HD) in the UK. This vaccine is designed for people aged 65 and older, as well as clinically at-risk ...
Factors associated with increased flare rates post-vaccination included active disease at the time, female sex, and -- most ...
CSL Seqirus, Sanofi and GSK have collectively secured ... In an abundance of caution, we are taking steps to increase the amount of vaccine that could be immediately available if needed.” ...
Reading, UK – 15 October 2024 – Sanofi has today announced the launch of high-dose egg-based quadrivalent influenza vaccine (QIV-HD) in the UK for people aged 65 years or older, and clinically ...
MANILA, Philippines — French pharmaceutical giant Sanofi Pasteur’s motion for reconsideration on a ruling related to its controversial Dengvaxia dengue vaccine has been denied by the Court of ...
Moreover, Le Berrigaud’s confidence is bolstered by the recent positive developments, including the approval of a second manufacturing line for the vaccine Beyfortus in the US, allowing Sanofi ...